文献速递糖尿病肥胖与代谢综合征

超重与肥胖对无糖尿病男女空腹胰岛素分泌的影响:效应量与机制

Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.
PubMed 文献 · Diabetologia · 2025-12-18

基于EGIR-RISC队列1250名健康参与者随访3.5年,评估肥胖对空腹胰岛素分泌的影响。肥胖对空腹胰岛素分泌的影响在BMI和WHR全范围呈连续变化且男性更明显,脂肪量和腰围是最强预测因子,空腹胰岛素分泌随BMI十分位增加2.4倍,肥胖相关胰岛素高分泌由高血糖和β细胞功能变量ISR@5上调共同驱动,肝葡萄糖过度生成可能参与肥胖者空腹高胰岛素血症。

要点

  • 肥胖对空腹胰岛素分泌的影响在BMI和WHR全范围呈连续变化,男性效应大于女性。
  • 脂肪量和腰围是空腹胰岛素分泌的最强预测因子,空腹胰岛素分泌随BMI十分位增加2.4倍。
  • 减重可降低空腹胰岛素分泌和空腹血糖,肝葡萄糖过度生成可能参与肥胖者空腹高胰岛素血症。

核心结论

  • 肥胖对胰岛素分泌的影响是连续的、男性更明显,由脂肪量和腰围驱动,由高血糖和β细胞胰岛素分泌上调维持,仅部分由肥胖的典型激素和代谢后果解释。
  • 肝葡萄糖过度生成可能参与肥胖个体观察到的空腹高胰岛素血症。

研究设计与样本

  • 分析EGIR-RISC队列1250名健康参与者(547名男性,703名女性),年龄30-60岁,BMI 18.5-40.0 kg/m2,随访3.5年。
  • 评估体成分、胰岛素分泌、基于OGTT的β细胞功能建模和钳夹衍生的胰岛素敏感性;在368名参与者亚组中测量内源性葡萄糖生成(EGP)。
  • 采用多变量回归模型并按BMI、体脂百分比、WHR和脂肪量分层,评估肥胖对胰岛素分泌和β细胞功能的影响。

主要发现

  • 肥胖对空腹胰岛素分泌(FIS)的影响在BMI和WHR全范围呈连续变化,且男性大于女性。
  • 脂肪量(标准化β系数[Stβ] 0.27,p<0.0001)和腰围(Stβ 0.21,p<0.0001)是FIS的最强预测因子。
  • 空腹胰岛素分泌随BMI十分位增加2.4倍,肥胖相关胰岛素高分泌似乎由高血糖和特定β细胞功能变量(5 mmol/l葡萄糖时胰岛素分泌率[ISR@5])增加共同驱动。
  • 随访队列中,体重增加(平均±SD ∆体重=+5.1 ± 3.8 kg)与FIS和空腹血糖增加相关(+0.20 ± 0.63 mmol/l,p<0.03),而体重减轻(-4.7 ± 2.8 kg)导致FIS和空腹血糖降低(+0.06 ± 0.55 mmol/l,p<0.006)。
  • ISR@5在体重减轻者和体重稳定者中下降(分别为-0.17 ± 1.9和-0.16 ± 1.0 U/h,两者p<0.002),但在体重增加者中未下降(-0.06 ± 1.1 U/h)。

临床怎么用

  • 临床评估肥胖相关高胰岛素血症时,应关注脂肪量和腰围而非仅BMI,并注意男性效应更明显。
  • 减重可降低空腹胰岛素分泌和空腹血糖,支持体重管理作为改善胰岛素高分泌的干预方向。
  • 肥胖者空腹高胰岛素血症可能部分反映肝葡萄糖过度生成,评估时需综合考虑肝脏胰岛素作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Fasting hyperinsulinaemia is a key feature of obesity and is implicated in diabetes progression. However, the following aspects of insulin secretion remain unclear: (1) which index of obesity is most important; (2) what is the shape of the dose-response curve between obesity and insulin secretion; (3) what physiological mechanisms sustain insulin hypersecretion; (4) what are the underlying causes; and (5) whether sex-related differences exist. METHODS: We analysed data from 1250 healthy participants (547 men, 703 women) of the EGIR-RISC cohort followed up for 3.5 years, with age 30-60 years and BMI 18.5-40.0 kg/m2. Assessments included body composition, insulin secretion, beta cell function modelling from an OGTT and clamp-derived insulin sensitivity. Endogenous glucose production (EGP) was measured in a subset of 368 participants. Multivariable regression models and stratifications for BMI, body fat per cent, WHR and fat mass were applied to evaluate the effect of obesity on insulin secretion and beta cell function. RESULTS: The impact of obesity on fasting insulin secretion (FIS) was continuous across the full spectrum of BMI and WHR values and was greater in men than women. Among adiposity indices, fat mass (standardised β coefficient [Stβ] 0.27, p<0.0001) and waist circumference (Stβ 0.21, p<0.0001) were the strongest predictors of FIS. Insulin secretion increased 2.4-fold across BMI deciles, and adiposity-associated insulin hypersecretion appeared to be driven by the combination of hyperglycaemia and an increase in a specific beta cell function variable (insulin secretion rate at 5 mmol/l glucose [ISR@5]). In the follow-up cohort, weight gain (mean ± SD ∆ weight=+5.1 ± 3.8 kg) was associated with an increase in FIS and fasting glucose (+0.20 ± 0.63 mmol/l, p<0.03), whereas weight loss (-4.7 ± 2.8 kg) led to a reduction in FIS and fasting glucose (+0.06 ± 0.55 mmol/l, p<0.006). ISR@5 declined in both weight losers and those with stable weight (-0.17 ± 1.9 and -0.16 ± 1.0 U/h, respectively; p<0.002 for both) but not in weight gainers (-0.06 ± 1.1 U/h). Peripheral insulin resistance, plasma NEFA and leptin accounted for only part of obesity's effect on insulin secretion. Subset analysis of fasting and clamp EGP data suggested a rightwards shift in the dose-response curve across fat mass quintiles, indicating progressive hepatic glucose overproduction despite a preserved hepatic insulin response. CONCLUSIONS/INTERPRETATION: The effect of body mass on insulin secretion is continuous, more pronounced in men, driven by fat mass and waist, sustained by hyperglycaemia and by an upregulation of beta cell insulin secretion and is only partially explained by typical hormonal and metabolic consequences of obesity. We suggest that hepatic glucose overproduction contributes to the fasting hyperinsulinaemia observed in individuals with obesity.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Chiriacò M, Tricò D, Petrie JR, et al. Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms. Diabetologia. 2025. PMID: 41413296. doi:10.1007/s00125-025-06643-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。